Viewing Study NCT01021956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-07-13 @ 2:36 PM
Study NCT ID: NCT01021956
Status: TERMINATED
Last Update Posted: 2018-09-17
First Post: 2009-11-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
Sponsor: Steba Biotech S.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Degeneration View
None Choroidal Neovascularization View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Macular Degeneration View
None Age Related Macular Degeneration View
None Choroidal Neovascularization View
None AMD View
None CNV View
None WST11 View
None Stakel View
None Photodynamic therapy View
None Vascular Targeted Photodynamic therapy View
None VTP View